BIOMAT Database Logo BIOMAT Database Logo

[Hormonal tissue concentration and oral contraceptives: the endometrium]. 1979

A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D003278 Contraceptives, Oral, Hormonal Oral contraceptives which owe their effectiveness to hormonal preparations. Hormonal Oral Contraceptive,Hormonal Oral Contraceptive Agent,Contraceptive Agents, Estrogen,Contraceptive Agents, Oral, Hormonal,Hormonal Oral Contraceptive Agents,Oral Contraceptive Agents, Hormonal,Oral Contraceptives, Hormonal,Contraceptive, Hormonal Oral,Contraceptives, Hormonal Oral,Estrogen Contraceptive Agents,Hormonal Oral Contraceptives,Oral Contraceptive, Hormonal
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D005260 Female Females

Related Publications

A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
The endometrium and hormonal contraceptives.
June 2000, Human reproduction (Oxford, England),
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[Changes in the endometrium from the use of hormonal preparations and hormonal contraceptives].
January 1978, Arkhiv patologii,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
Oral hormonal contraceptives affect the concentration and composition of urinary glycosaminoglycans in young women.
November 2009, International urogynecology journal and pelvic floor dysfunction,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[Hormonal oral contraceptives, coagulation and thrombosis].
December 2001, Revista clinica espanola,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[Oral hormonal contraceptives and carbohydrate metabolism].
May 1996, Ginecologia y obstetricia de Mexico,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[Hormonal contraceptives for oral use].
January 1965, Akusherstvo i ginekologiia,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
The effects of oral contraceptives on the endometrium.
January 1968, International journal of fertility,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[Oral hormonal contraceptives and benign liver tumors].
February 1981, Fortschritte der Medizin,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[New progestins in oral hormonal contraceptives].
January 1989, Archives of gynecology and obstetrics,
A Carranco López, and I Sojo Aranda, and R Alonso Uriarte, and G Castañeda Peña, and N Bedolla Tovar, and M Navarrete Arellano, and V Cortés Gallegos
[Oral contraceptives with lower hormonal dosis].
August 1976, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!